Earnings Summary

Passage Bio Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Passage Bio Inc has generated NaN% jump in its revenue since last 3-months.

Passage Bio Inc’s net profit fell -4.77% since last year same period to $-27.11Mn in the Q3 2023. On a quarterly growth basis, Passage Bio Inc has generated -13.64% fall in its net profits since last 3-months.

Passage Bio Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Passage Bio Inc has generated NaN% jump in its net profit margins since last 3-months.

Passage Bio Inc’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a 4.35% jump from last quarter’s estimates.

Passage Bio Inc’s earning per share (EPS) estimates for the current year stand at -0.44.

Passage Bio Inc’s earning per share (EPS) jumped 0% since last year same period to -0.49 in the Q3 2023. This indicates that the Passage Bio Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Passage Bio Inc’s return on assets (ROA) stands at -0.3.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Passage Bio Inc’s return on equity (ROE) stands at -0.64.